Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02988817
Brief Title: Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

First Submitted : December 1, 2016
First Submitted that Met QC Criteria : December 8, 2016
First Posted : December 9, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 30, 2021
Last Update Posted : July 2, 2021